1-(4-Bromothiazol-2-yl)piperidin-4-ol, 95.0%, 1g

4-Chlorobenzo[d]oxazole, 95%, 5g

DIHYDROTANSHINONE I, 95%, 10mg

6-(Piperidin-1-yl)pyridine-3-carbaldehyde, 95+%, 1g

Lithiumtetraborat, min. 99 %, 100 g, kunststoffverpackung.

Imidazol-1-yl-acetic acid, 99.00%, 100g

4-(2,6-DICHLORO-PHENYL)-PIPERIDINE HCL, 95.0%, 2g

[4-(1-methoxyethyl)phenyl]boronic acid, 95.0%, 10g

1,11-Diamino-3,6,9-trioxaundecane>97.0%(GC)(T)1g

(S)-1-(3-Fluorophenyl)-N-methylethanamine, 97%, 250mg

N-(2-phenylethyl)-4-piperidinecarboxamide dihydrochloride, 95.0%, 5g

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 60 m, Ø-Innen 0,25 mm, Filmd. 0,10 µm, 1 Stück

2-Bromo-4-chloro-5-iodotoluene, 1g